ID | 119581 |
Title Alternative | 分泌型frizzled関連蛋白(SFRP)を用いた子宮肉腫に対する新たな治療戦略の検討
UTERINE SARCOMA TREATMENT WITH SECRETED FRIZZLED‑RELATED PROTEINS
|
Author |
Nakagawa, Tomotaka
Tokushima University
Shinohara, Ayaka
Tokushima University
Arakaki, Ryosuke
Tokushima University
Inui, Hiroaki
Tokushima University
Noguchi, Hiroki
Tokushima University
Yoshida, Kanako
Tokushima University
Tokushima University Educator and Researcher Directory
KAKEN Search Researchers
Kaji, Takashi
Tokushima University
Tokushima University Educator and Researcher Directory
KAKEN Search Researchers
Nishimura, Masato
Tokushima University
Tokushima University Educator and Researcher Directory
KAKEN Search Researchers
Iwasa, Takeshi
Tokushima University
Tokushima University Educator and Researcher Directory
KAKEN Search Researchers
|
Keywords | secreted frizzled‑related protein
uterine sarcoma
Wnt signaling pathway
migration
adhesion
|
Content Type |
Thesis or Dissertation
|
Description | Secreted frizzled‑related proteins (SFRPs) are involved in the development of various types of cancer and function by suppressing the Wnt signaling pathway. To elucidate the clinical implications of SFRPs in uterine sarcoma, SFRP expression levels and their effects on uterine leiomyosarcoma cells were examined. Immunostaining for SFRP4 was performed on uterine smooth muscle, uterine fibroid and uterine leiomyosarcoma tissues. Additionally, the effects of SFRP4 administration on cell viability, migration and adhesion were evaluated in uterine leiomyosarcoma SKN cells using the WST‑1 assay (Roche Diagnostics) and the CytoSelect™ 24‑well Cell Migration Assay Kit and the CytoSelect™ 48‑well Cell Adhesion Assay Kit. The expression levels of SFRP4 in uterine leiomyosarcoma tissues were lower than those in normal smooth muscle and uterine fibroid tissues. In addition, SFRP4 suppressed the viability and migration, and increased the adhesion ability of uterine leiomyosarcoma cells compared with in the control group. In conclusion, SFRP4 may suppress the viability and migration, and enhance the adhesion of sarcoma cells. These results suggested that SFRP4 could be considered as a novel therapeutic target for uterine sarcoma.
|
Journal Title |
Experimental and Therapeutic Medicine
|
ISSN | 17920981
17921015
|
NCID | AA12610820
|
Publisher | Spandidos Publications
|
Volume | 27
|
Issue | 5
|
Start Page | 231
|
Published Date | 2024-03-26
|
Remark | 内容要旨・審査要旨・論文本文の公開
本論文は,著者TOMOHIRO KAGAWAの学位論文として提出され,学位審査・授与の対象となっている。 Kagawa T, Mineda A, Nakagawa T, Shinohara A, Arakaki R, Inui H, Noguchi H, Yoshida A, Kinouchi R, Yamamoto Y, Yamamoto Y, et al: New treatment strategies for uterine sarcoma using secreted frizzled‑related proteins. Exp Ther Med 27: 231, 2024 |
DOI (Published Version) | |
URL ( Publisher's Version ) | |
FullText File | |
language |
eng
|
TextVersion |
ETD
|
MEXT report number | 甲第3838号
|
Diploma Number | 甲医第1614号
|
Granted Date | 2024-07-25
|
Degree Name |
Doctor of Medical Science
|
Grantor |
Tokushima University
|
departments |
University Hospital
Medical Sciences
|